USPTO trademark

OPTIVEC

RegisteredUSPTOWord markClass 5Class 42

"OPTIVEC" is a word mark owned by Glaxo Group Limited, filed at the USPTO on May 19, 2021. It is registered and covers classes 5 and 42.

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
OPTIVEC trademark as filed
As filed with the USPTO
Status
Registered
Since October 11, 2022
Filed
May 19, 2021
Registered
October 11, 2022
Priority date
February 2, 2021
Claimed from United Kingdom
Application no.
90720340
Registration no.
6869125
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns OPTIVEC

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

Glaxosmithkline

Goods and services

What the mark covers

The products and services OPTIVEC is filed for, grouped by Nice class.

  • Biological preparations for medical use for gene transfer for the treatment of cancer; Biological preparations in the nature of lentiviral particles for DNA, RNA and protein transfer for medical use for the treatment of cancer; all of the foregoing being gene therapy products

  • Scientific research and development services in the field of DNA, RNA and protein transfer by lentiviral particles; Scientific research and development services in the field of cell and gene therapies; all of the foregoing in the field of gene therapy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Teas change of correspondence received
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Notice of registration confirmation emailed
  10. Registered-principal register

10 earlier steps on the official record.

FAQ

About OPTIVEC

Who owns the trademark "OPTIVEC"?

The USPTO trademark "OPTIVEC" (application 90720340) is owned by Glaxo Group Limited.

What is the status of "OPTIVEC"?

Its status at the USPTO is: registered.

When was "OPTIVEC" registered?

It was registered on October 11, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OPTIVEC and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d58-7b0d-735f-b133-95b7d8584935
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d58-7b0d-735f-b133-95b7d8584935",
  "object": "trademark",
  "mark_text": "OPTIVEC",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90720340",
  "filing_date": "2021-05-19",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}